Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model

Toxicology Letters

Volumn 206, Issue 3, 2011, Pages 268-275

  Hollebeeck, Sylvie ^a   Raas, Thomas ^a   Piront, Neil ^b   Schneider, Yves Jacques ^a   Toussaint, Olivier ^b   Larondelle, Yvan ^a   During, Alexandrine ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b University of Namur   (Belgium)

Author keywords

Caco 2 cells; COX 2 activity; Cytokines; Dimethyl sulfoxide; Intestinal inflammation; Transcriptional study

Indexed keywords

CYCLOOXYGENASE 2; DIMETHYL SULFOXIDE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECRETION;

ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; CHEMOKINE CCL2; DIMETHYL SULFOXIDE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; NF-KAPPA B; RNA, MESSENGER;

EID: 80052535624     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.08.010     Document Type: Article

References (58)

1. Al-Sadi R., Ye D., Said H.M., Ma T.Y. IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway. Am. J. Pathol. 2010, 177:2310-2322.
2. Atreya R., Neurath M.F. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin. Rev. Allergy Immunol. 2005, 28:187-196.
3. Barnes P.J. Nuclear factor-kappa B. Int. J. Biochem. Cell Biol. 1997, 29:867-870.
4. Basak S., Shih V.F., Hoffmann A. Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system. Mol. Cell. Biol. 2008, 28:3139-3150.
5. Bektasoglu B., Esin Celik S., Ozyurek M., Guclu K., Apak R. Novel hydroxyl radical scavenging antioxidant activity assay for water-soluble antioxidants using a modified CUPRAC method. Biochem. Biophys. Res. Commun. 2006, 345:1194-1200.
6. Blanco F.J., Guitian R., Moreno J., de Toro F.J., Galdo F. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J. Rheumatol. 1999, 26:1366-1373.
7. Bookman A.A., Williams K.S., Shainhouse J.Z. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 2004, 171:333-338.
8. Brockmann R., Beyer A., Heinisch J.J., Wilhelm T. Posttranscriptional expression regulation: what determines translation rates?. PLoS Comput. Biol. 2007, 3:e57.
9. Chang C.K., Llanes S., Schumer W. Inhibitory effect of dimethyl sulfoxide on nuclear factor-kappa B activation and intercellular adhesion molecule 1 gene expression in septic rats. J. Surg. Res. 1999, 82:294-299.
10. Da Violante G., Zerrouk N., Richard I., Provot G., Chaumeil J.C., Arnaud P. Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. Biol. Pharm. Bull. 2002, 25:1600-1603.
11. Daig R., Andus T., Aschenbrenner E., Falk W., Scholmerich J., Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996, 38:216-222.
12. De Bosscher K., Vanden Berghe W., Haegeman G. Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 2006, 25:6868-6886.
13. DeForge L.E., Fantone J.C., Kenney J.S., Remick D.G. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J. Clin. Invest. 1992, 90:2123-2129.
14. Djan T.I., Gunberg D.L. Percutaneous absorption of two steroids dissolved in dimethyl sulfoxide in the immature female rat. Ann. N. Y. Acad. Sci. 1967, 141:406-413.
15. Duque J., Diaz-Munoz M.D., Fresno M., Iniguez M.A. Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells. Cell. Signal. 2006, 18:1262-1269.
16. Egorin M.J., Rosen D.M., Sridhara R., Sensenbrenner L., Cottler-Fox M. Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem-cell transplants. J. Clin. Oncol. 1998, 16:610-615.
17. Essani N.A., Fisher M.A., Jaeschke H. Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 1997, 7:90-96.
18. Evans M.S., Reid K.H., Sharp J.B. Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia. Neurosci. Lett. 1993, 150:145-148.
19. Feng L., Xia Y., Garcia G.E., Hwang D., Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J. Clin. Invest. 1995, 95:1669-1675.
20. Gloire G., Legrand-Poels S., Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 2006, 72:1493-1505.
21. Hoang B.X., Levine S.A., Shaw D.G., Tran D.M., Tran H.Q., Nguyen P.M., Tran H.D., Hoang C., Pham P.T. Dimethyl sulfoxide as an excitatory modulator and its possible role in cancer pain management. Inflamm. Allergy Drug Targets 2010, 9:306-312.
22. Hucker H.B., Ahmad P.M., Miller E.A., Brobyn R. Metabolism of dimethyl sulphoxide to dimethyl sulphone in the rat and man. Nature 1966, 209:619-620.
23. Hucker H.B., Miller J.K., Hochberg A., Brobyn R.D., Riordan F.H., Calesnick B. Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man. J. Pharmacol. Exp. Ther. 1967, 155:309-317.
24. Ikawa H., Kameda H., Kamitani H., Baek S.J., Nixon J.B., Hsi L.C., Eling T.E. Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells. Exp. Cell Res. 2001, 267:73-80.
25. Ingels F., Beck B., Oth M., Augustijns P. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Int. J. Pharm. 2004, 274:221-232.
26. Jacob S.W., Herschler R. Dimethyl sulfoxide after twenty years. Ann. N. Y. Acad. Sci. 1983, 411:xiii-xvii.
27. Jacob S.W., Herschler R. Pharmacology of DMSO. Cryobiology 1986, 23:14-27.
28. Jiang Y.J., Hatch G.M., Mymin D., Dembinski T., Kroeger E.A., Choy P.C. Modulation of cytosolic phospholipase A(2) by PPAR activators in human preadipocytes. J. Lipid Res. 2001, 42:716-724.
29. Kelly K.A., Hill M.R., Youkhana K., Wanker F., Gimble J.M. Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect. Immun. 1994, 62:3122-3128.
30. Khan W.I., Motomura Y., Wang H., El-Sharkawy R.T., Verdu E.F., Verma-Gandhu M., Rollins B.J., Collins S.M. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G803-G811.
31. Klein S.M., Cohen G., Cederbaum A.I. Production of formaldehyde during metabolism of dimethyl sulfoxide by hydroxyl radical generating systems. Biochemistry 1981, 20:6006-6012.
32. Kolb K.H., Janicke G., Kramer M., Schulze P.E., Raspe G. The behavior of 35S tagged dimethyl sulfoxide in the human and the animal organism. Arzneimittelforschung 1965, 15:1292-1295.
33. Kuehl F.A., Egan R.W. Prostaglandins, arachidonic acid, and inflammation. Science 1980, 210:978-984.
34. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect. Biol. 2009, 1:a001651.
35. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
36. Moon M.R., Parikh A.A., Pritts T.A., Kane C., Fischer J.E., Salzman A.L., Hasselgren P.O. Interleukin-1beta induces complement component C3 and IL-6 production at the basolateral and apical membranes in a human intestinal epithelial cell line. Shock 2000, 13:374-378.
37. Nakamuta M., Ohta S., Tada S., Tsuruta S., Sugimoto R., Kotoh K., Kato M., Nakashima Y., Enjoji M., Nawata H. Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Int. J. Mol. Med. 2001, 8:553-560.
38. Notman R., Noro M., O'Malley B., Anwar J. Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes. J. Am. Chem. Soc. 2006, 128:13982-13983.
39. Panganamala R.V., Sharma H.M., Heikkila R.E., Geer J.C., Cornwell D.G. Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesis. Prostaglandins 1976, 11:599-607.
40. Parhar K., Ray A., Steinbrecher U., Nelson C., Salh B. The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. Immunology 2003, 108:502-512.
41. Pearson T.W., Dawson H.J., Lackey H.B. Natural occurring levels of dimethyl sulfoxide in selected fruits, vegetables, grains, and beverages. J. Agric. Food Chem. 1981, 29:1089-1091.
42. Reinecker H.C., Loh E.Y., Ringler D.J., Mehta A., Rombeau J.L., MacDermott R.P. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995, 108:40-50.
43. Romier B., Schneider Y.J., Larondelle Y., During A. Dietary polyphenols can modulate the intestinal inflammatory response. Nutr. Rev. 2009, 67:363-378.
44. Salim A.S. Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach. J. Lab. Clin. Med. 1992, 119:710-717.
45. Santos N.C., Figueira-Coelho J., Martins-Silva J., Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem. Pharmacol. 2003, 65:1035-1041.
46. Satriano J.A., Shuldiner M., Hora K., Xing Y., Shan Z., Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J. Clin. Invest. 1993, 92:1564-1571.
47. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 2006, 25:6685-6705.
48. Sekizuka E., Benoit J.N., Grisham M.B., Granger D.N. Dimethylsulfoxide prevents chemoattractant-induced leukocyte adherence. Am. J. Physiol. 1989, 256:H594-H597.
49. Sergent T., Piront N., Meurice J., Toussaint O., Schneider Y.J. Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. Chem. Biol. Interact. 2010, 188:659-667.
50. Simic M.G. Mechanisms of inhibition of free-radical processes in mutagenesis and carcinogenesis. Mutat. Res. 1988, 202:377-386.
51. Stallmach A., Giese T., Schmidt C., Ludwig B., Mueller-Molaian I., Meuer S.C. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int. J. Colorectal Dis. 2004, 19:308-315.
52. Swanson B.N. Medical use of dimethyl sulfoxide (DMSO). Rev. Clin. Basic Pharm. 1985, 5:1-33.
53. Van De Walle J., Hendrickx A., Romier B., Larondelle Y., Schneider Y.J. Inflammatory parameters in Caco-2 cells: effect of stimuli nature, concentration, combination and cell differentiation. Toxicol. In Vitro 2010, 24:1441-1449.
54. Vlahopoulos S., Boldogh I., Casola A., Brasier A.R. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 1999, 94:1878-1889.
55. Wang D., DuBois R.N. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett. 2008, 267:197-203.
56. Williams A.C., Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 2004, 56:603-618.
57. Winrow V.R., Winyard P.G., Morris C.J., Blake D.R. Free radicals in inflammation: second messengers and mediators of tissue destruction. Br. Med. Bull. 1993, 49:506-522.
58. Xing L., Remick D.G. Mechanisms of dimethyl sulfoxide augmentation of IL-1 beta production. J. Immunol. 2005, 174:6195-6202.